Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene

AIDS Research and Human Retroviruses

Volumn 15, Issue 16, 1999, Pages 1441-1452

  Ometto, Lucia ^a   Zanchetta, Marisa ^a   Cabrelle, Anna ^a   Esposito, Giovanni ^a   Mainardi, Monica ^a   Chieco Bianchi, Luigi ^a   De Rossi, Anita ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CHEMOKINE RECEPTOR CCR5; DNA; MESSENGER RNA;

ARTICLE; CASE REPORT; CELL PROTECTION; GENE DELETION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION SENSITIVITY; MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION;

ADULT; DNA, VIRAL; FEMALE; GENE DELETION; HETEROZYGOTE; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033230332     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309955     Document Type: Article

References (56)

1. Fenyö EM, Morfeldt-Manson L, Chiodi F, Lind B, von-Gegerfelt A, Albert J, Olausson E, and Åsjö A: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-4419.
2. Tersmette M, De Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, and Miedema F: Differential syncytium inducing capacity of human immunodeficiency virus isolates: Frequent detection of synctium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988;62:2026-2032.
3. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, and Miedema F: Biological phenotype of human immunodeficiency virus type 1 clones at different stage of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus population. J Virol 1992;66:1354-1360.
4. Zhu T, Mo H, Wang N, Dam DS, Cao Y, Koup RA, and Ho DD: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-1181.
5. Connor RI and Ho DD: Human immunodeficiency virus type 1 variants with increased replicative capacity develope during the asymptomatic stage before disease progression. J Virol 1994;68: 4400-4408.
6. Doms RW and Peiper SC: Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology 1997;235:179-190.
7. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
8. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
9. Deng H, Liu R, Ellmeier W, Choe S, Unitmaz D, Burkhart M, Di Marzio P, Marmon S, Suttons RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996; 381:661-666.
10. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
11. Berger EA, Doms RW, Fenjo EM, Korber BT, Littman DR, Moore JP, Sattentau GJ, Schuitemaker H, Sodroski J, and Weiss RA: A new classification for HIV-1. Nature (London) 1998;391:240.
12. Rana S, Besson G, Cook DG, Rucker J, Smyth RJ, Yi Y, Turner JD, Guo HH, Du JG, Peiper SC, Lavi E, Samson M, Libert F, Liesnard C, Bassart G, Doms RW, Parmentier M, and Collman RG: Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the Δccr5 mutation. J Virol 1997;71:3219-3227.
13. Quillent C, Oberlin E, Braun J, Roussel D, Gonzalez-Canali G, Métais P, Montagnier L, Virelizier JL, Arenzana-Seisdedos F, and Beretta A: HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351:14-18.
14. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
15. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, Vandevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup R: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996;2:412-417.
16. Connor RI, Paxton WA, Sheridan KE, and Koup RA: Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. J Virol 1996; 70:8758-8764.
17. Dean M, Carrington M, Winkler C, Huttley A, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vitinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinado C, Detels R, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
18. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
19. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, and Sheppard HW: The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-340.
20. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
21. Blaak H, van't Wout AB, Brouwer M, Cornelissen M, Kootstra NA, Albrecht-van Lent N, Keet RPM, Goudsmit J, Coutinho RA, and Schuitemaker H: Infectious cellular load in human immundeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J Virol 1998;72:218-224.
22. Picchio GR, Gulizia RJ, and Mosier DE: Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. J Virol 1997;71:7124-7127.
23. Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I, and the SEROCO Study Group: Early protective effect of CCR-5A32 heterozygosity on HIV-1 disease progression: Relationship with viral load. AIDS 1997;11:F73-F78.
24. Vant' Wout AB, Koostra NA, Mulder-Kampinga GA, Albrechtvan Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, and Schuitemaker H: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994;94:2060-2067.
25. Ometto L, Zanotto C, Maccabruni A, Caselli D, Truscia D, Giaquinto C, Ruga E, Chieco-Bianchi L, and De Rossi A: Viral phenotype and host cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995;9: 427-434.
26. Salvatori F, Masiero S, Giaquinto C, Wade CM, Leigh Brown AJ, Chieco-Bianchi L, and De Rossi A: Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol 1997;71:4694-4706.
27. Spencer LT, Ogino MT, Dankner WM, and Spector SA: Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children. J Infect Dis 1994;169:491-195.
28. Bryson YJ: Perinatal HIV-1 transmission: Recent advances and therapeutic interventions. AIDS 1997;10:S33-S42.
29. Fear WR, Kesson AM, Naif H, Lynch GW, and Cunningham AL: Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998;72: 1334-1344.
30. De Rossi A, Ometto L, Mammano F, Zanotto C, Giaquinto C, and Chieco-Bianchi L: Vertical transmission of HIV-1: Lack of detectable virus in peripheral blood cells of infected children at birth. AIDS 1992;6:1117-1120.
31. De Rossi A, Giaquinto C, Ometto L, Mammano F, Zanotto C, Dunn D, and Chieco-Bianchi L: Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993;123:929-936.
32. Hill CM, Deng H, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK, Zolla-Pazner S, and Littman DR: Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make CD4-dependent interactions with this chemokine receptors. J Virol 1997;71:6296-6304.
33. Salvatori F, De Martino M, Galli L, Vierucci A, Chieco-Bianchi L, and De Rossi A: Horizontal transmission of human immunodeficiency virus type 1 from father to child. AIDS Res Hum Retroviruses 1998;14:1679-1685.
34. Samson M, Liebert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulle C, Georges M, Imal T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Bassart G, and Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 1996;382:722-725.
35. De Rossi A, Masiero S, Giaquinto C, Ruga E, Comar M, Giacca M, and Chieco-Bianchi L: Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996;97:323-330.
36. Verani A, Scarlatti G, Comar M, Tresoldi E, Polo S, Giacca M, Lusso P, Siccardi AG, and Vercelli D: C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cell. J Exp Med 1997;185:805-816.
37. Cocchi F, De Vico AL, Grazino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, MIP-1β as the major HIV suppressive factors produced by CD8+ T-cells. Science 1995;270:1811-1815.
38. Margolis LB, Blushakova S, Grivel JC, and Murphy PM: Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J Clin Invest 1998;101:1876-1880.
39. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Procl Natl Acad Sci USA 1997;94:1925-1930.
40. Naif HM, Li S, Alali M, Sloane A, Wu L, Kelly M, Lynch G, Lloyd A, and Cunnigham AL: CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998;72:830-836.
41. Ledbetter JA, Evans RL, Lipinski M, Cunningham-Rundles C, Good RA, and Herzenberg LA: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and T cytotoxic/suppressor subpopulations in mouse and man. J Exp Man 1981;153:310-323.
42. Wood GS, Warner NL, and Warnke RA: Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol 1983;1321:212-216.
43. Kim A, Pettoello-Mantovani M, and Goldstein H: Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:145-149.
44. Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, Mackay C, and Koup RA: Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of β-chemokines. Virology 1998;244:66-73.
45. Tuttle DL, Harrison JK, Anders C, Sleasman JW, and Goodenow MM: Expression of CCR5 increases during monocyte differentiation and directly mediates macrophages susceptibility to infection by human immunodeficiency virus type 1: J Virol 1998;72: 4962-4969.
46. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, and Kabat D: Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:2855-2864.
47. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of a new CC-chemokine receptor gene, CC-CKR5. Biochemistry 1996;11:3362-3367.
48. Benkirane M, Jin DY, Chun RF, Koup RA, and Jeang KT: Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 1997;272:30603-30606.
49. Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, Czeizel A, Claustres M, de la Rùa C, Ferrari M, Ferrec C, Glover G, Grinde B, Guran S, Kucinskas V, Lavinha J, Mercier B, Ogur G, Peltonen L, Rosatelli C, Schwarte M, Spitsyn V, Timar L, Beckman L, Parmentier M, and Vassart G: The Δ32 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in the northeastern Europe. Hum Mol Genet 1998;7:399-406.
50. Eldestein RE, Manns Arcuino LA, Hughes JP, Melvin AJ, Mohan KM, King PD, McLellan CL, Murante BL, Kassman BP, and Frenkel LM: Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/Δ32ccr5 heterozygotes. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:243-246.
51. Rousseau CM, Jurst JJ, Abrams EJ, Casabona J, Stein Z, and King MC: CCR5del132 in perinatal infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:239-242.
52. Shearer WT, Kalish LA, Zimmerman PA for the Women and Infants Transmission Study Group: CCR5 HIV-1 vertical transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:180.
53. Misrahi M, Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S, for the French Pediatric HIV Infection Study Group: CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 1998;279:277-280.
54. Mandl CW, Aberle SW, Henkel JH, Puchhammer-Stockl, and Heinz FX: Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1. J Med Virol 1998;55:51-55.
55. Van't Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, and Schuitemaker H: Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 1998; 72:488-496.
56. Mammano F, Salvatori F, Ometto L, Panozzo M, Chieco-Bianchi L, and De Rossi A: V3 loop and phenotype of human immunodeficiency virus type 1 (HIV-1) isolates from children with perinatally acquired HIV-1 infection. J Virol 1995;69:82-92.